Clinical cases of the treatment of metastatic colorectal cancer in Russia
The article presents the clinical cases of the targeted therapy regorafenib in metastatic colorectal cancer (mCRC) in Russia. Russian oncologists’ experience has not only confirmed the results of international clinical trials, but also clearly demonstrated the possibility of regorafenib long-term ad...
Main Authors: | V E Goldberg, A I Hasanova, V V Shkuratova, Yu V Belevich, N O Popova, E I Simolina, V V Vysockaya, E A Dudnikova, T L Kravchuk, R R Minnabetdinova, O V Nekrasova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Habib O.N.
2017-12-01
|
Series: | Современная онкология |
Subjects: | |
Online Access: | https://modernonco.orscience.ru/1815-1434/article/viewFile/27161/pdf |
Similar Items
-
Using of multi-kinase inhibitor regorafenib for metastatic colorectal cancer
by: O I Kit, et al.
Published: (2017-06-01) -
NEW POSSIBILITIES OF THERAPY OF INTENSIVELY PRETREATED METASTATIC COLORECTAL CANCER PATIENTS
by: E. V. ARTAMONOVA
Published: (2016-12-01) -
Practice patterns and outcomes with the use of regorafenib in metastatic colorectal cancer: Results from the Regorafenib in Metastatic colorectal cancer - An Indian exploratory analysis study
by: Anant Ramaswamy, et al.
Published: (2019-01-01) -
Modern possibilities of targeted therapy in metastatic colorectal cancer
by: V A Gorbunova
Published: (2015-12-01) -
Hospitalizations and Clinical Outcome in Metastatic Colorectal Cancer During Regorafenib or TAS-102 Therapy
by: Florian Huemer, et al.
Published: (2020-09-01)